In the News

Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc [More Details]

Medical Professionals Become an LDN Specialist [More Details]

LDN Articles from general news sources

Phentermine Online Weight Loss Clinic Review - Where to buy best prescription diet pills (News)
Read More
Find out if you qualify for these clinical trials enrolling now (News)
Read More
LDN & Better Sleep (News)
Read More
Low-Dose Naltrexone Offers New Hope for Pain Sufferers (News)
Read More
Low Dose Naltrexone Easing Pain from Fibromyalgia and Other Painful Conditions (News)
Read More
Solutions for Small Intestinal Bacterial Overgrowth (News)
Read More
Low-Dose Naltrexone Holds Promise for Relief of Phantom Limb Pain (News)
Read More
Low-dose Naltrexone Changes Levels of Inflammatory Proteins in MS, Study Shows (News)
Read More
Immunometabolic Modulatory Role of Naltrexone in BV-2 Microglia Cells (News)
Read More
Low-dose naltrexone: tricking the body to heal itself (News)
Read More
The AMA’s Contribution to the Opioid Epidemic (News)
Read More
LDN Side Effect Survey Results 2021
Read More
Guest column: Don't neglect long-haul Covid in the panic over delta
Read More
Can common drugs offer 2-step approach to combat deadly virus? (News)
Read More
Drug relieves chronic pain without the addiction risk (News)
Read More
Medicine specialist talks treatments for lingering COVID-19 symptoms (News)
Read More
Can low-dose naltrexone relieve pain? (News)
Read More
Low-Dose Naltrexone for Fibromyalgia and ME/CFS (News)
Read More
VIDEO: Low-dose naltrexone shows promise in two patients with ‘complex’ refractory Crohn’s (News)
Read More
Phase 2 Trial to Evaluate Safety and Efficacy of CYTO-205 in Mild COVID-19 (Study)
Read More
Recovering from COVID Long-Hauler Syndrome (News)
Read More
Got Inflammation? How LDN can help in the times of Covid-19 (News)
Read More
Nonopioid Analgesic, Nonpharmacologic Options for Pain Management Reviewed (News)
Read More
LDN And Rheumatoid Arthritis (News)
Read More
Research roundup: Recent grants and publications for Emory faculty and staff (News)
Read More
AgelessRx Launches Pilot Post-COVID Clinical Trial Using LDN and NAD (News)
Read More
Statera Biopharma and Immune Therapeutics Inc. Announce Strategic Agreement for Rights to Low Dose Naltrexone (News)
Read More
Scientists get first look at T cell responses in Ebola virus survivors (News)
Read More
How Chronic Pain Can Lead to Autoimmunity Problems (News)
Read More
Naltrekson ograniczył ból związany z zespołem piekących ust (News)
Read More
McLaughlin leads research on identifying minimally invasive biomarkers for MS (News)
Read More
What is the evidence behind potential Low Dose Naltrexone benefits? (News)
Read More
Halberd Corp. Develops Medication to Boost Immune System Against SARS-CoV-2 (Covid-19) (News)
Read More
Low-Dose Naltrexone for Autoimmune and Chronic Pain Conditions, Podcast Interview (News)
Read More
Low-Dose Naltrexone Used as Alternative to Opioids for Chronic Pain Patients (News)
Read More
Data from First Phase III Clinical Study of PXT3003 in Charcot-Marie-Tooth Disease Type 1A... (News)
Read More
Calls for the radical treatment (News)
Read More
Research suggests toll-like receptor 4 appears to play role in severe COVID (News)
Read More
Low-Dose Naltrexone May Be Opioid Replacement for Chronic Pain (News)
Read More
New research gives hope to COVID-19 long haul carriers (News)
Read More
Low Dose Naltrexone Emerging as Treatment for Intractable Pain (News)
Read More
Repurposing low-dose naltrexone (LDN) for the prevention and treatment of immunothrombosis in COVID-19 (News)
Read More